Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells

Journal of Molecular Endocrinology

Volumn 51, Issue 1, 2013, Pages 181-189

  Bulotta, Stefania ^a   Corradino, Rosanna ^a   Celano, Marilena ^a   Maiuolo, Jessica ^a   D'Agostino, Maria ^a   Oliverio, Manuela ^a   Procopio, Antonio ^a   Filetti, Sebastiano ^b   Russo, Diego ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Akt; MAP kinase; Oleuropein; ROS; Thyroid cancer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; OLEUROPEIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRYPAN BLUE;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; THYROID CANCER; WESTERN BLOTTING;

AKT; MAP KINASE; OLEUROPEIN; ROS; THYROID CANCER;

ANTIOXIDANTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; PYRANS; REACTIVE OXYGEN SPECIES; THYROID NEOPLASMS;

EID: 84879972190     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0241     Document Type: Article

References (39)

1. Achat S, Tomao V, Madani K, Chibane M, Elmaataoui M, Dangles O & Chemat F 2012 Direct enrichment of olive oil in oleuropein by ultrasound-assisted maceration at laboratory and pilot plant scale. Ultrasonics Sonochemistry 19 777-786 (10.1530/JME-12-0241:10.1016/j.ultsonch.2011. 12.006)
2. Bible KC 2012 Individualization of therapies for patients with advanced differentiated thyroid cancers. Journal of Clinical Endocrinology and Metabolism 97 3092-3093. (10.1530/JME-12-0241:10.1210/jc.2012-2676)
3. Bulotta S, Ierardi MV, Maiuolo J, Cattaneo MG, Cerullo A, Vicentini LM & Borgese N 2009 Basal nitric oxide release attenuates cell migration of HeLa and endothelial cells. Biochemical and Biophysical Research Communications 386 744-749. (10.1530/JME-12-0241:10.1016/j.bbrc.2009.06.118)
4. Bulotta S, Corradino R, Celano M, D'Agostino M, Maiuolo J, Oliverio M, Procopio A, Iannone M, Rotiroti D & Russo D 2011 Antiproliferative and antioxidant effects of oleuropein and its semisynthetic peracety-lated derivatives on breast cancer cells. Food Chemistry 127 1609-1614. (10.1530/JME-12-0241:10.1016/j.foodchem.2011.02.025)
5. Celano M, Calvagno MG, Bulotta S, Paolino D, Arturi F, Rotiroti D, Filetti S, Fresta M & Russo D 2004 Cytotoxic effects of Gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells. BMC Cancer 4 63. (10.1530/JME-12-0241:10.1186/1471-2407-4-63)
6. Celano M, Schenone S, Cosco D, Navarra M, Puxeddu E, Racanicchi L, Brullo C, Varano E, Alcaro S, Ferretti E et al. 2008 Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo. Endocrine-Related Cancer 15 499-510. (10.1530/JME-12-0241:10.1677/ERC-07-0243)
7. Cicerale S, Lucas L & Keast R 2010 Biological activities of phenolic compounds present in virgin olive oil. International Journal of Molecular Sciences 11 458-479. (10.1530/JME-12-0241:10.3390/ijms11020458)
8. Crouzeix G, Michels JJ, Sevin E, Aide N, Vaur D & Bardet S 2012 Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 97 3046-3050. (10.1530/JME-12-0241:10.1210/jc.2012-1630)
9. D'Agostino M, Voce P, Celano M, Sponziello M, Moretti S, Maggisano V, Verrienti A, Durante C, Filetti S, Puxeddu E et al. 2012 Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells. Thyroid 22 138-144. (10.1530/JME-12-0241:10.1089/thy. 2011.0060)
10. Duracková Z 2010 Some current insights into oxidative stress. Physiological Research 59 459-469.
11. El SN & Karakaya S 2009 Olive tree (Olea europaea) leaves: potential beneficial effects on human health. Nutrition Reviews 67 632-638. (10.1530/JME-12-0241:10.1111/j.1753-4887.2009.00248.x)
12. Fagin JA & Mitsiades N 2008 Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Practice & Research. Clinical Endocrinology & Metabolism 22 955-969. (10.1530/JME-12-0241:10.1016/j.beem.2008. 09.017)
13. Gild ML, Bullock M, Robinson BG & Clifton-Bligh R 2011 Multikinase inhibitors: a new option for the treatment of thyroid cancer. Nature Reviews. Endocrinology 7 617-624. (10.1530/JME-12-0241:10.1038/nrendo.2011.141)
14. Goulas V, Exarchou V, Troganis AN, Psomiadou E, Fotsis T, Briasoulis E & Gerothanassis IP 2009 Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells. Molecular Nutrition & Food Research 53 600-608. (10.1530/JME-12-0241:10.1002/mnfr.200800204)
15. Hall SF, Walker H, Siemens R & Schneeberg A 2009 Increasing detection and increasing incidence in thyroid cancer. World Journal of Surgery 33 2567-2571. (10.1530/JME-12-0241:10.1007/s00268-009-0226-9)
16. Hamdi HK & Castellon R 2005 Oleuropein, a non-toxic olive iri10.1530/JME-12-0241d, is an anti-tumor agent and cytoskeleton disruptor. Biochemical and Biophysical Research Communications 334 769-778. (10.1530/JME-12-0241:10.1016/j.bbrc.2005.06.161)
17. Harris PJ & Bible KC 2011 Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches. Expert Opinion on Investigational Drugs 20 1357-1375. (10.1530/JME-12-0241:10.1517/13543784.2011. 614230)
18. Knauf JA & Fagin JA 2009 Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets. Current Opinion in Cell Biology 21 296-303. (10.1530/JME-12-0241:10.1016/j.ceb.2009.01.013)
19. Markopoulos C, Vertzoni M, Agalias A, Magiatis P & Reppas C 2009 Stability of oleuropein in the human proximal gut. Journal of Pharmacy and Pharmacology 61 143-149. (10.1530/JME-12-0241:10.1211/jpp.61.02.0002)
20. Mateos M, Goya L & Bravo L 2005 Metabolism of the olive oil phenols hydroxytyrosol, tyrosol, and hydroxytyrosyl acetate by human hepatoma HepG2 cells. Journal of Agricultural and Food Chemistry 53 9897-9905. (10.1530/JME-12-0241:10.1021/jf051721q)
21. Notarnicola M, Pisanti S,Tutino V, Bocale D, Rotelli MT, Gentile A,Memeo V, Bifulco M, Perri E & Caruso MG 2010 Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. Genes & Nutrition 6 63-69. (10.1530/JME-12-0241:10.1007/s12263-010-0177-7)
22. Odiatou EM, Skaltsounis AL & Constantinou AI 2013 Identification of the factors responsible for the in vitro pro-oxidant and cytotoxic activities of the olive polyphenols oleuropein and hydroxytyrosol. Cancer Letters 330 113-121. (10.1530/JME-12-0241:10.1016/j.canlet.2012.11.035)
23. w: biodistribution, pharmacokinetic features and in vivo antitumor activity. Journal of Controlled Release 144 144-150. (10.1530/JME-12-0241:10.1016/j.jconrel.2010.02.021)
24. Procopio A, Sindona G, Gaspari M, Costa N & Nardi M 2008 Chemicalcatalytic method 286 for the peracylation of oleuropein and its products of hydrolysis. International Patent no. 287 PCT/IT2008/000303.
25. Procopio A, Alcaro S, Nardi M, Oliverio M, Ortuso F, Sacchetta P, Pieragostino D & Sindona G 2009 Synthesis, biological evaluation, and molecular modeling of oleuropein and its semisynthetic derivatives as cyclooxygenase inhibitors. Journal of Agricultural and Food Chemistry 57 11161-11167. (10.1530/JME-12-0241:10.1021/jf9033305)
26. Puxeddu E, Durante C, Avenia N, Filetti S & Russo D 2008 Clinicalimplication of BRAF mutation in thyroid carcinoma. Trends in Endocrinology and Metabolism 19 138-145. (10.1530/JME-12-0241:10.1016/j.tem.2007.12.003)
27. Ribeiro FR, Meireles AM, Rocha AS & Teixeira MR 2008 Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples. BMC Cancer 8 371. (10.1530/JME-12-0241:10.1186/1471-2407-8-371)
28. Russo D, Damante G, Puxeddu E, Durante C & Filetti S 2011 Epigenetics of thyroid cancer and novel therapeutic targets. Journal of Molecular Endocrinology 46 R73-R81. (10.1530/JME-12-0241:10.1530/JME-10-0150)
29. Schlumberger M & Sherman SI 2009 Clinical trials for progressive differentiated thyroid cancer: patient selection, study design, and recent advances. Thyroid 19 1393-1400. (10.1530/JME-12-0241:10.1089/thy. 2009.1603)
30. Schlumberger M & Sherman SI 2012 Approach to the patient with advanced differentiated thyroid cancer. European Journal of Endocrinology 166 5-11. (10.1530/JME-12-0241:10.1530/EJE-11-0631)
31. Schlumberger M, Lacroix L, Russo D, Filetti S & Bidart JM 2007 Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients. Nature Clinical Practice. Endocrinology & Metabolism 3 260-269. (10.1530/JME-12-0241:10.1038/ncpendmet0449)
32. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC et al. 2008 Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. Journal of Clinical Endocrinology and Metabolism 93 4331-4341. (10.1530/JME-12-0241:10.1210/jc.2008-1102)
33. Sirianni R, Chimento A, De Luca A, Casaburi I, Rizza P, Onofrio A, Iacopetta D, Puoci F, Ando S, Maggiolini M et al. 2010 Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Molecular Nutrition & Food Research 54 833-840. (10.1530/JME-12-0241:10.1002/mnfr.200900111)
34. Spano JP, Vano Y, Vignot S, De La Motte Rouge T, Hassani L, Mouawad R, Menegaux F, Khayat D & Leenhardt L 2012 GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma.Medical Oncology 29 1421-1428. (10.1530/JME-12-0241:10.1007/s12032-011-0070-2)
35. Trapasso F, Iuliano R, Chiefari E, Arturi F, Stella A, Filetti S, Fusco A & Russo D 1999 Iodide symporter gene expression in normal and transformed rat thyroid cells. European Journal of Endocrinology 140 447-451. (10.1530/JME-12-0241:10.1530/eje.0.1400447)
36. Visioli F, Poli A & Galli C 2002 Antioxidant and other biological activities of phenols from olives and olive oil. Medicinal Research Reviews 22 65-75 (10.1530/JME-12-0241:10.1002/med.1028)
37. Wang D, Feng JF, Zeng P, Yang YH, Luo J & Yang YW 2011 Total oxidant/antioxidant status in sera of patients with thyroid cancers.Endocrine-Related Cancer 18 773-782. (10.1530/JME-12-0241:10.1530/ERC-11-0230)
38. Xing M 2007 Gene methylation in thyroid tumorigenesis. Endocrinology 148 948-953. (10.1530/JME-12-0241:10.1210/en.2006-0927)
39. Xing M 2012 Oxidative stress: a new risk factor for thyroid cancer.Endocrine-Related Cancer 19 C7-C11. (10.1530/JME-12-0241:10.1530/ERC-11-0360)